Javascript must be enabled to continue!
Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
View through CrossRef
Abstract
Recognition of MHC + peptide complexes by TCRs is thought to involve a large surface formed by exposed residues from the bound peptide and from the alpha-helices of the MHC protein. This interaction appears to be essentially symmetrical in the positioning of the TCR relative to the MHC molecule. In this study the topology of HLA-B27 recognition by an alloreactive TCR, 64.8P, has been analyzed with a panel of site-specific mutants that have changes at multiple positions along the peptide binding site of HLA-B27. Abrogation of transfectant target cell lysis by CTL 64.8P was obtained only with some mutations in the peptide side chain binding pockets A and B, whereas little or no effect was observed with mutations outside these pockets. CTL 64.8P efficiently lysed murine transfectant cells, including HLA-B27+ RMA-S cells. Recognition of this latter transfectant was more efficient upon increased HLA-B27 expression at 26 degrees C. The uneven distribution of mutations affecting HLA-B27 allorecognition by CTL 64.8P strongly suggests an asymmetrical topology in the interaction of this TCR with HLA-B27, in which most of the binding energy is provided by contacts with HLA-B27 and/or peptide residues located close to pockets A and B, with little contribution from other areas of the MHC or peptide molecules. Its conservation in RMA-S cells further suggests that the epitope recognized by CTL 64.8P is either peptide-independent or requires any of a set of peptides having the same amino-terminal residues.
Oxford University Press (OUP)
Title: Unusual topology of an HLA-B27 allospecific T cell epitope lacking peptide specificity.
Description:
Abstract
Recognition of MHC + peptide complexes by TCRs is thought to involve a large surface formed by exposed residues from the bound peptide and from the alpha-helices of the MHC protein.
This interaction appears to be essentially symmetrical in the positioning of the TCR relative to the MHC molecule.
In this study the topology of HLA-B27 recognition by an alloreactive TCR, 64.
8P, has been analyzed with a panel of site-specific mutants that have changes at multiple positions along the peptide binding site of HLA-B27.
Abrogation of transfectant target cell lysis by CTL 64.
8P was obtained only with some mutations in the peptide side chain binding pockets A and B, whereas little or no effect was observed with mutations outside these pockets.
CTL 64.
8P efficiently lysed murine transfectant cells, including HLA-B27+ RMA-S cells.
Recognition of this latter transfectant was more efficient upon increased HLA-B27 expression at 26 degrees C.
The uneven distribution of mutations affecting HLA-B27 allorecognition by CTL 64.
8P strongly suggests an asymmetrical topology in the interaction of this TCR with HLA-B27, in which most of the binding energy is provided by contacts with HLA-B27 and/or peptide residues located close to pockets A and B, with little contribution from other areas of the MHC or peptide molecules.
Its conservation in RMA-S cells further suggests that the epitope recognized by CTL 64.
8P is either peptide-independent or requires any of a set of peptides having the same amino-terminal residues.
Related Results
High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors
High Resolution HLA-A, HLA-B, and HLA-C Allele Frequencies in Romanian Hematopoietic Stem Cell Donors
The HLA genes are associated with various autoimmune pathologies, with the control of the immune response also being significant in organs and cells transplantation. The aim of the...
Immunoradiometric assay for the rapid detection of HLA‐B27
Immunoradiometric assay for the rapid detection of HLA‐B27
SummaryA new method for the rapid detection of the HLA‐B27 antigen is discussed which consists of a direct immunoradiometric assay (IRA) utilizing a 125I‐labelled, HLA‐B27 specific...
Diversity of HLA Class I and II Genes in the North Indian Population
Diversity of HLA Class I and II Genes in the North Indian Population
Introduction: Numerous studies have concentrated on specific populations to explore the extensive polymorphism of class I and II HLA genes. This genetic diversity is crucial for va...
Diagnostic accuracy of PD weighed MRI /STIR sequence to determine periarticular bone marrow edema of <10mm depth in predicting acute sacroilliatis in relation with HLA B27
Diagnostic accuracy of PD weighed MRI /STIR sequence to determine periarticular bone marrow edema of <10mm depth in predicting acute sacroilliatis in relation with HLA B27
Background: Acute sacroiliitis is a critical early feature of axial spondyloarthritis (axSpA), and timely diagnosis is essential to prevent irreversible structural damage. Magnetic...
Diagnostic accuracy of PD weighed MRI /STIR sequence to determine periarticular bone marrow edema of <10mm depth in predicting acute sacroilliatis in relation with HLA B27
Diagnostic accuracy of PD weighed MRI /STIR sequence to determine periarticular bone marrow edema of <10mm depth in predicting acute sacroilliatis in relation with HLA B27
Background: Acute sacroiliitis is a critical early feature of axial spondyloarthritis (axSpA), and timely diagnosis is essential to prevent irreversible structural damage. Magnetic...
Expression of human HLA-B27 transgene alters susceptibility to murine Theiler’s virus-induced demyelination
Expression of human HLA-B27 transgene alters susceptibility to murine Theiler’s virus-induced demyelination
Abstract
Infection of certain strains of mice with Theiler’s murine encephalomyelitis virus results in persistence of virus and an immune-mediated primary demyelinat...
CD34 negative HLA‐DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3‐ITD mutations
CD34 negative HLA‐DR negative acute myeloid leukaemia: A higher association with NPM1 and FLT3‐ITD mutations
AbstractIntroductionCD34 and HLA‐DR negativity is often used as a characteristic immunophenotypic feature of acute promyelocytic leukaemia (APL) that differentiates APL from other ...
Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.
Aurora-A Kinase: A Novel Target for the Immunotherapy Against Human Leukemias.
Abstract
Aurora-A kinase (Aurora-A) is one of the serine/threonine kinase families, which is located on the long arm of chromosome 20q13, is mainly expressed in G2/M...

